Invesco Ltd. Charles River Laboratories International, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 1,108,358 shares of CRL stock, worth $150 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,108,358

Previous 1,034,180 7.17%

Holding current value

$150 Million

Previous $191 Million 12.61%

% of portfolio

0.03%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$150.52 - $190.14 $11.2 Million - $14.1 Million	74,178 Added 7.17%	1,108,358 $167 Million
Q4 2024 Feb 13, 2025	BUY	$178.58 - $220.69 $27 Million - $33.4 Million	151,159 Added 17.12%	1,034,180 $191 Million
Q3 2024 Nov 12, 2024	SELL	$187.96 - $245.29 $21.2 Million - $27.7 Million	-112,891 Reduced 11.34%	883,021 $174 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $21.3 Million - $27.8 Million	103,388 Added 11.58%	995,912 $206 Million
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $11.4 Million - $15.3 Million	-55,794 Reduced 5.88%	892,524 $242 Million
Q4 2023 Feb 12, 2024	BUY	$164.52 - $238.84 $3.36 Million - $4.88 Million	20,423 Added 2.2%	948,318 $224 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $14.8 Million - $16.5 Million	75,978 Added 8.92%	927,895 $182 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $11.5 Million - $13.2 Million	62,853 Added 7.97%	851,917 $179 Million
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $21.2 Million - $28.7 Million	-110,426 Reduced 12.28%	789,064 $159 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $24.9 Million - $31.6 Million	-126,369 Reduced 12.32%	899,490 $196 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $14.2 Million - $19.5 Million	77,975 Added 8.23%	1,025,859 $202 Million
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $654,236 - $969,191	-3,205 Reduced 0.34%	947,884 $203 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $118 Million - $167 Million	-461,955 Reduced 32.69%	951,089 $270 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $19.1 Million - $24.3 Million	-54,267 Reduced 3.7%	1,413,044 $532 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $9.14 Million - $11.2 Million	24,526 Added 1.7%	1,467,311 $606 Million
Q2 2021 Aug 17, 2021	BUY	$294.17 - $371.65 $96.9 Million - $122 Million	329,426 Added 29.59%	1,442,785 $534 Million
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $124 Million - $148 Million	495,568 Added 80.22%	1,113,359 $323 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $43.3 Million - $49.2 Million	194,941 Added 46.1%	617,791 $154 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $35.1 Million - $45.3 Million	200,048 Added 89.79%	422,850 $95.8 Million
Q2 2020 Aug 14, 2020	SELL	$118.84 - $189.72 $3.1 Million - $4.95 Million	-26,072 Reduced 10.48%	222,802 $38.8 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $2.41 Million - $4.34 Million	24,346 Added 10.84%	248,874 $31.4 Million
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $1.62 Million - $1.96 Million	-12,833 Reduced 5.41%	224,528 $34.3 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $4.74 Million - $5.45 Million	-37,935 Reduced 13.78%	237,361 $31.4 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $7 Million - $8.43 Million	56,735 Added 25.96%	275,296 $39.1 Million
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $6.18 Million - $8.66 Million	-59,003 Reduced 21.26%	218,561 $31.7 Million
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $29.2 Million - $38.1 Million	277,564 New	277,564 $31.4 Million

Others Institutions Holding CRL

# of Institutions

650

Shares Held

55M

Call Options Held

695K

Put Options Held

809K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $6.87B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account